Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Health

Announcement: Neurobiotech Press Conference at the European Parliament, 2nd April 2014


Print article Print article
2014-03-21 21:48:37 - Brussels: Neuromed and ISC will organize a press conference at the European Parliament on 2nd April to brief European media about the R&D and Innovation capabilities of Neuromed.

The Neuromed-led project "Neurobiotech" is aimed at setting up an International Research and Innovation Community on Neuroscience. Neurobiotech will be a scientific cluster where research, innovation, technology transfer and training will be focused on the common goal of sharing and integrating knowledge, stimulating research activities in the field of Neuroscience with a multidisciplinary approach, by encouraging research, exchange of know-how, intensive interaction and the joint use of infrastructures, facilities and services with high added value.

Neurobiotech is promoted by Neuromed, a research centre recognized by the Italian Ministry of Health as highly qualified research and clinical organization specialized in Neuroscience in cooperation with the Molise Regional Government, the Italian National Research Council, the Universities of Rome Sapienza, Tor Vergata and

Molise. Several foreign research centres and companies have already agreed to participate in the cluster.

Speakers of the Press Conference will include:
• Jacopo Meldolesi - Chief Scientific Officer Neurobiotech Project
• Paolo di Laura Frattura - President of Molise Region
• Luigi Frati - Scientific Director of INM Neuromed I.R.C.C.S and Rector of University Sapienza of Rome

The Molise Regional Government, as partner of the project, will consider the proposal as a pilot project for the definition of the strategic framework of the regional cohesion policy. Within the framework of the Neurobiotech cluster, the Molise region has set aside financial resources for companies and research centres wishing to invest in Molise, therefore, contributing to a knowledge-based economy. It will be the first experiment of integrating European resources managed both by the European Commission and Local Authorities.

The research and innovation activities will be directed towards the development of the following fields of specialisation:

• Cutting-edge Neuroscience and Biotechnology;
• Neurotechnologies;
• Stem cells, Tissue engineering and Cell biology;
• Genomics;
• Nanotechnology and Biomaterials;
• Biomechanics and Robotics;
• Human Brain Interface;
• Neurodiagnostics;
• Telemedicine and Telediagnostics;
• Microelectronics;
• Bioinformatics;
• Advanced Imaging.

The press conference will be an excellent platform for media and interested stakeholders to learn about the R&D and Innovation capabilities of Neuromed in general and Neurobiotech specifically. Media will also have the opportunity to ask questions and conduct interviews.

Date and Time: 2nd April, 14.00-15.00
Location: European Parliament, Room ASP 5G2

Media Inquiries

Declan Kirrane
ISC Intelligence in Science
Email: declan.kirrane@iscintelligence.com
Tel: +32 2 8888 100
www.iscintelligence.com

Or

Jessica Hadjis
ISC Intelligence in Science
Email: jessica.hadjis@iscintelligence.com
Phone: +32 2 8888 100
Mob: +32 487 163 107
www.iscintelligence.com

Editor’s Note

I.R.C.C.S. NEUROMED

Assistance, Research, Training & Education

The Neuromed Institute is a center dedicated exclusively to monospecialisti Neurology, Neurosurgery and Neurorehabilitation. At the clinic, specialists of the afore mentioned disciplines work in synergy and conduct collaborative scientific research activities.

Further information: www.neuromed.it/?lang=en


Contact Information:
ISC Intelligence in Science

Rue de Trône, 4
1000 - Brussels (Belgium)

Contact Person:
Jessica Hadjis

Phone: + 32 2 8888 100
email: email

Web: www.iscintelligence.com



Author:
Pilar Gomez
e-mail
Web: www.iscintelligence.com
Phone: 003228888100

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com